The largest database of trusted experimental protocols

Complete protease and phosphatase inhibitors

Manufactured by Roche
Sourced in United States, Switzerland

Complete protease and phosphatase inhibitors are a set of reagents designed to provide broad-spectrum inhibition of proteases and phosphatases in biological samples. These inhibitors help preserve the integrity of proteins and their post-translational modifications during sample preparation and processing.

Automatically generated - may contain errors

28 protocols using complete protease and phosphatase inhibitors

1

Immunoprecipitation and Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Neurons were lysed in 1×RIPA buffer (Pierce Biotechnology, Rockford, IL) with complete phosphatase and protease inhibitors (Roche, Indianapolis, IN) and spun at 1,000×g for 10 min to obtain supernatants. Protein concentrations were measured using BCA protein assay kit (Pierce). For immunoprecipitations, supernatants (300 µg) were first precleared with protein A/G-agarose beads (Santa Cruz Biotechnology, Santa Cruz, CA) and mixed with anti-STEP antibody (4 µg) overnight at 4°C as described [37 (link)]. On the second day, protein A/G-agarose was added to the antibody-bound complex for 4 h at 4°C and precipitates were washed 3 times with 1×RIPA buffer and analyzed by SDS-PAGE and immunoblotting.
+ Open protocol
+ Expand
2

Dissociated Hippocampal Neuron Treatment Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
All procedures were approved by the Yale University Institutional Animal Care and Use Committee. Primary dissociated hippocampal cultures were prepared from Sprague–Dawley rat at embryonic day 18 and plated on poly-D-lysine-coated plates (1 × 106 cells/well) in Neurobasal supplemented with 2% B27 (Invitrogen, San Diego, CA) and grown for 18–21 days as described33 (link). At 18–21 days in vitro, neurons were treated with muscarine (10 μM) plus NMDA (50 μM) dissolved in ECS for 10 min. In some groups, inhibitors and antagonists (pirenzepine: 10 μM; EGTA/AM: 0.1 or 1 mM; TC-2153: 1 μM; xestospongin C: 10 μM; PP2: 10 μM or PP3: 10 μM) or vehicle (0.1% DMSO) were added 30 min before and throughout the treatment with muscarine and NMDA. After treatments, neurons were lysed in 1 × RIPA buffer (Pierce Biotechnology, Rockford, IL) with complete phosphatase and protease inhibitors (Roche, Indianapolis, IN).
+ Open protocol
+ Expand
3

PCP-induced Neuronal Injury Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
All experimental procedures were approved by the Yale University Institutional Animal Care and Use Committee and were in strict accordance with the NIH Guide for the Care and Use of Laboratory Animals. Primary cortical neurons were isolated from rat or mouse E18 embryos as described [33 (link)]. Neuronal cultures were maintained in a Neurobasal medium with B27 supplement (Invitrogen, San Diego, CA, USA) for 12–14 days. Cultures were then treated with PCP (10 μM) for 24 h, while in some experiments, the STEP inhibitor (TC-2153, 1 μM) was added 1 h prior to PCP and was present throughout the 24-h PCP treatment. Neurons were lysed in 1× RIPA buffer (Pierce Biotechnology, Rockford, IL, USA) with complete phosphatase and protease inhibitors (Roche, Indianapolis, IN, USA). Lysates were spun at 1000×g for 10 min to isolate homogenates.
+ Open protocol
+ Expand
4

Primary Cortical Neuron Culture and Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
All experimental procedures were approved by the Yale University Institutional Animal Care and Use Committee and in strict accordance with the NIH Guide for the Care and Use of Laboratory Animals. Primary cortical cultures were derived from rat Sprague-Dawley E18 embryos (Jackson Laboratory, Bar Harbor, Maine) as described (Xu et al. 2014 (link)). Both male and female embryos were used in this study. Neuronal cultures were maintained in Neurobasal with B27 supplement (Invitrogen, San Diego, CA) for 12-14 days until treatment. Cultures were treated with three doses of 7,8-DHF (100, 250 and 500 nM) for 5-30 min. In some experiments, inhibitors (K252a: 100 nM and lactacystin: 5 μM) were pre-incubated for 30-60 min, followed by 7,8-DHF (500 nM, 30 min) or LM 22A4 (500 nM, 30 min) treatment. Neurons were lysed in 1×RIPA buffer (Pierce Biotechnology, Rockford, IL) with complete phosphatase and protease inhibitors (Roche, Indianapolis, IN).
+ Open protocol
+ Expand
5

HNRNPA2B1 Protein Quantification by WB

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole cell extracts (WCE) were prepared in RIPA buffer (Sigma-Aldrich) with added phosphatase and complete protease inhibitors (Roche, Indianapolis, IN, USA). Protein concentrations were determined using the Bio-Rad DC protein assay (Bio-Rad, Hercules, CA, USA). 40 or 45 µg of WCE protein were electrophoresed on 10% SDS-PAGE gels and electroblotted on PVDF membranes (Bio-Rad) for western blotting with the following antibodies: HNRNPA2B1 (B1 epitope-specific32 (link)) antibody # 18941 from IBL America (Minneapolis, MN USA); GAPDH cat.# sc-365062 (Santa Cruz Biotechnology, Dallas, TX, USA); β-actin (cat. # A5316, Sigma-Aldrich). Bands were visualized using a Bio Rad ChemiDoc MP imager and quantified by UN-SCAN-IT Graph Digitizer Software 7.1 (Silk Scientific, Orem, UT, USA).
+ Open protocol
+ Expand
6

Immunoprecipitation of STAT3 and GRN

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunoprecipitations were performed as previously described [27 (link)]. Briefly, cells (5 × 106) were lysed on ice for 15 minutes in lysis buffer [50mM Tris (pH 7.5), 150 mM NaCl, 0.5% NP40] with phosphatase and complete protease inhibitors (Roche, Indianapolis, IN). Five percent of the total protein lysate (approximately 12.5 μg of 250 μg) was saved as an immunoprecipitation input loading control, then the remaining lysate was divided into equal volumes for overnight incubation at 4 °C with 1 μg of an antibody to STAT3 (sc-482, Santa Cruz Biotechnology, Inc., Dallas, TX), GRN (40-3400, Invitrogen, Grand Island, NY), or isotype control IgG (Caltag, Burlingame, CA). The lysate-antibody mixture was incubated for 4 hours at 4 °C with protein A/G PLUS agarose beads (Santa Cruz) blocked with 1% bovine serum albumin (Sigma-Aldrich) for 1 hour at 4 °C. The antibody-bead mixture was washed 3 times in lysis buffer, and eluted in sample buffer with10% β-mercaptoethanol.
+ Open protocol
+ Expand
7

Western Blot Analysis of Akt and FOXO1 Phosphorylation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell monolayers were washed twice with ice-cold PBS and lysed directly in ice-cold RIPA buffer (Pierce) containing a phosphatase and complete protease inhibitors (Roche) and a total of 30 μg protein of each sample run on 10% SDS-PAGE gels, and blotted onto nitrocellulose or PVDF membranes as described57 (link). Membranes were blocked in TBS-T (25 mM Tris–HCl, pH 7.5, 150 mM NaCl, and 0.1% Tween 20) containing 5% (w/v) fat-free milk for 1–2 h and incubated with primary antibodies at the concentration indicated (Table S2) in TBS-T containing 5% BSA overnight at 4 °C. After washing in TBS-T (4 × 10 min), the blots were incubated for 1 h with a 1:10,000 dilution of the appropriate horseradish peroxidase-conjugated antibody (Cell Signalling Technologies) in TBS-T containing 5% (w/v) fat-free milk for 1 h at room temperature and proteins detected by enhanced chemiluminescence. Following the detection of phosphorylated Akt, or FOXO1 membranes were stripped in NaOH (200 mM) for 20 min at room temperature and re-probed for total Akt or FOXO1 protein respectively and β-actin, or α/β tubulin used as a loading control.
+ Open protocol
+ Expand
8

Immunoprecipitation of Phosphorylated MED1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed in cold lysis buffer using the aforementioned lysis buffer with complete protease and phosphatase inhibitors (Roche Applied Science). Precleared cell lysate was incubated with anti-Flag or anti-p-MED1 antibodies overnight and then with ultralink immobilized protein A/G plus beads (Thermo Scientific) for 24 hours. Beads were washed four times with cold lysis buffer, and then samples were degenerated by boiling. Lastly, immune complexes were applied in Western blotting as previously described.
+ Open protocol
+ Expand
9

Protein Extraction from Organoids

Check if the same lab product or an alternative is used in the 5 most similar protocols
Organoids were collected in cold medium and mechanically separated from the Matrigel by pipetting several times. The organoids were centrifuged at 1,200 rpm for 5 min and resuspended in cold medium, and this process was repeated at least twice to dissolve the Matrigel. Cells were lysed using modified RIPA lysis buffer (150 mM NaCl, 50 mM Tris HCl, pH 7.6, 5 mM NaF, 5 mM β-glycerophosphate, 1 mM EDTA, 1 mM Na-orthovanadate, 1% Na-deoxycholate, and 1% NP-40) containing complete protease and phosphatase inhibitors (both from Roche). Protein content was quantified using standard Bradford assay. For WB analysis, 15 µg of protein was loaded per lane and transferred to a nitrocellulose membrane and probed with the antibodies described in Table S2 C.
+ Open protocol
+ Expand
10

Protein Quantification in Cell and Tissue Lysates

Check if the same lab product or an alternative is used in the 5 most similar protocols
MLE 12 cells were lysed with ice-cold Pierce cell lysis buffer with complete protease and phosphatase inhibitors (Roche). Lung tissues were lysed with ice-cold lysis buffer #6 (R&D Systems) and then homogenized and sonicated on ice. Cleaved caspase-3 (#9664), total caspase-3 (#9662), cleaved PARP (#94885), or β-actin (#4970) antibodies were purchased from Cell Signaling Technology. Membranes were developed with chemiluminescent substrate (34095, ThermoFisher) using an Amersham 600 imager (General Electric).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!